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Abstract
Background: The aimof this studywas to describe the experience of pediatric and young adult hemodialysis (HD) patients from
a global cohort.
Methods: The Pediatric Investigation and Close Collaborative Consortium for Ongoing Life Outcomes for MONitoring Dialysis
Outcomes (PICCOLO MONDO) study provided de-identified electronic information of 3244 patients, ages 0–30 years from 2000 to
2012 in four regions: Asia, Europe, North America and South America. The study samplewas categorized into pediatric (≤18 years
old) and young adult (19–30 years old) groups based on the age at dialysis initiation.
Results: For those with known end-stage renal disease etiology, glomerular disease was the most common diagnosis in
children and young adults. Using Europe as a reference group, North America [odds ratio (OR) 2.69; CI 1.29, 5.63] and South
America (OR 4.21; CI 2.32, 7.63) had the greatest mortality among young adults. North America also had higher rates of
overweight, obesity, hypertension, cardiovascular disease, hospitalizations and secondary diabetes compared with all other
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regions. Initial catheter use was greater for North American (86.4% in pediatric patients and 75.2% in young adults) and South
America (80.6% in pediatric patients and 75.9% in young adults). Catheter use at 1-year follow-up was most common in North
American children (77.3%) and young adults (62.9%). Asia had the lowest rate of catheter use. For both age groups, dialysis
adequacy (equilibrated Kt/V) ranged between 1.4 and 1.5. In Asia, patients in both age groups had significantly longer treatment
times than in any other region.
Conclusions: The PICCOLO MONDO study has provided unique baseline and 1-year follow-up information on children and
young adults receiving HD around the globe. This cohort has brought to light aspects of care in these age groups that warrant
further investigation.
Key words: adolescents, international, young adults
Introduction
Children, adolescents and young adults with end-stage renal dis-
ease (ESRD) constitute a group of patients with unique morbid-
ities. Their disease etiology is heterogeneous and varies greatly
by age, with congenital anomalies of the kidneys and urinary
tract (CAKUT) affecting younger individuals and acquired condi-
tions more prevalent in older patients [1, 2]. The incidence of
ESRD in the pediatric age group differs by region of the world
[1–4], and in some countries, an accurate estimate of the number
of patients with this condition is not available.
Investigation of comorbidities of pediatric hemodialysis (HD)
patients may underrepresent the 16- to 18-year-old patients, as a
number of adolescents are dialyzed in adult-focused units [5]. In
the USA, two-thirds of pediatric HD patients are treated at facil-
ities with fewer than 5% of patients younger than 19 years of
age. Furthermore, young adult patients on HD included in adult
studies do not share the comorbidities affecting the majority of
adult ESRD patients [6].
We describe the findings of the global Pediatric Investigation
and Close Collaborative Consortium for Ongoing Life Outcomes
for MONitoring Dialysis Outcomes (PICCOLO MONDO) study.
The PICCOLO MONDO is a subset of the volunteer global
MONDO consortium that reports data on patients maintained
on HD [7, 8]. The PICCOLO MONDO study characterized the inci-
dent and 1-year longitudinal outcomes of 0- to 30-year-old pa-
tients on HD.
Materials and methods
The ‘MONDO Consortium’ consists of dialysis facilities from the
Renal Research Institute in the USA; Fresenius Medical Care in
Europe, Asia Pacific and Latin America; KfH in Germany; Imperial
College in London, UK; Pontifical University of Parana in Curitiba,
Brazil; and Maastricht University Medical Center in The Nether-
lands [7, 8]. The MONDO database includes information on all
patients treated in their respective provider network with the
data directly extracted from the electronic health record systems.
Every individual provider has its own procedures for data clean-
ing before data end up in the respective provider system. The
MONDOdatabase contains only de-identified data. Research con-
ducted by MONDO complies with the Declaration of Helsinki.
MONDO partner organizations are responsible for the primary
collection and safeguarding of patient data in accordance with
all applicable local data protection laws and privacy protection
regulations. They also ensure full compliance with laws and reg-
ulations regarding the secondary use of data in the context of
MONDO. For data collection and analysis, local ethical, compli-
ance and legal standards are followed [7, 8]. This study was
approved by the University of North Carolina at Chapel Hill Insti-
tutional Review Board.
The PICCOLO MONDO cohort is a subset of MONDO and
includes patients from 0 to 30 years of age, from 510 units, and
in-center HD treatment data from 2000 to 2012. The study sample
was categorized into pediatric (≤18 years old) and young adult
(19–30 years old) groups based on the age at dialysis initiation. We
divided the regions of the world into Asia (Australia, Hong Kong,
South Korea, Malaysia, Philippines, Singapore, Turkey, Taiwan,
Thailand), Europe (Bosnia, Czech Republic, France, Hungary, Ire-
land, Italy, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slo-
venia, Spain, UK), North America (USA) and South America
(Argentina, Brazil, Chile, Colombia, Venezuela). Incident patients
and their 1-year outcomes were analyzed by age group and region.
The cause of ESRD was identified based on the International
Classification of Diseases (ICD)-9 (North America) and ICD-10
(Europe and Asia) codes. We converted ICD-10 categories to be
compatible with the ICD-9 codes. The data provided by dialysis
units in South America did not include cause of ESRD, whereas
the Asian data were organized into several categories of ESRD
etiology.
Given our large sample and for analysis purposes, we were
able to expand the diagnosis groups published by the pediatric
CKiD Study [9] into five groups as: glomerular, non-glomerular
(including CAKUT, and cystic and hereditary conditions), dia-
betes mellitus (DM), ‘other’ (e.g. tubulo-interstitial nephritis,
tubular necrosis) and ‘unknown’. Comorbidities examined such
as congestive heart failure, hypertension, secondary diabetes
and cardiovascular disease (CVD) excluding hypertension were
identified by each facility report.
Blood pressure parameters included pre-dialysis systolic
(preSBP) and pre-dialysis diastolic blood pressures (preDBP).
For the pediatric group, we defined hypertension using the
97th percentile for children with an inputted height of the age-
appropriate 50th percentile, using data generated in US children
and adolescents [10]. This definition accounted for potential re-
gional blood pressure differences related to height. For pediatric
patients, wederived the standard cutoff definitions of overweight
and obesity based on Cole et al. [11]. This group defined over-
weight as a body mass index (BMI) of 25–30 kg/m2 and obesity
as a BMI >30 kg/m2. For quality assurance, we set height limits
for patients less than 3 years of age at 100 cm and for those less
than 12 years of age at 170 cm.
Nutritional information included serum albumin, serum cre-
atinine and normalized protein catabolic rate (nPCR). Inflamma-
tory markers analyzed were C-reactive protein (CRP), ferritin and
neutrophil-to-lymphocyte ratio (NLR). Treatment and adequacy
measures included post-dialysis weight, inter-dialytic weight
gain (IDWG) as percent of post-dialysis weight, ultrafiltration
rate, treatment time, equilibrated Kt/V (eKt/V) and urea reduction
ratio (URR). For all clinical and laboratory parameters, the mean
of the first year on dialysis was used.



















We report odds ratio (OR) of death in the first year of dialysis in
the pediatric and young adult patients separately. For hospital
admissions, we constructed Poisson regression with number of
hospitalizations as the outcome with an offset for exposure
days. In both mortality and hospitalization analyses, Europe
was used as a reference group. Dialysis catheter use was deter-
mined at onset, at 6 months, and at 1 year or date of censoring
(whichever was earlier).
Data are presented as the mean with standard deviation for
continuous variables, and percent (%) for categorical variables.
One-way analysis of variance and χ2-tests were used to compare
continuous and categorical variables, respectively. Linear re-
gression was used to assess differences in patient treatment
and laboratory parameters adjusted for regional differences, as
well as age, gender and cause of ESRD. Univariate Kaplan–Meier
analysis was used to assess catheter prevalence by region at 183
and 365 days, and log-rank test was used for group comparison.
All P-values are two sided. The analyses were conducted using
SAS version 9.3 (SAS Institute, Cary, NC, USA).
Results
We included 3244 patients aged 0–30 years, with 418 (13%) in the
pediatric group aged 0–18 years, and 2826 (87%) in theyoung adult
group, aged 19–30 years. Sex, race and patient characteristics, in-
cluding cause of ESRD and comorbidities, are reported by region
in Table 1 (74% were white, 9% were black and 5% were of Asian
race). The age distribution is depicted in Figure 1. In the pediatric
group, the South America region has the greatest pediatric
representation, whereas the European region has the greatest
representation in the young adult group. Gender distribution
was similar in both age groups with the exception that there
were more males in the Asian pediatric group (62.8%). More
than 90% of patients were treated in HD units managed by
adult-focused providers.
Cause of ESRD
For those forwhoman ICD codewas provided, 16–55%had a diag-
nosis of ‘unknown’ cause of ESRD. Non-glomerular (GU) etiolo-
gies were most commonly reported in the European region in
both age groups. In the pediatric group, glomerular disease was
the most common cause of ESRD in the Asian and North Ameri-
can regions. In the young adult group, glomerular diseasewas the
most common cause in Asia and Europe, whereas ‘unknown’was
most common in North America. Diabetes as the primary cause
of ESRD was seen in Asia (2.3% of children and 11.6% of young
adults) and North America (2.3% in children and 13.0% of young
adults).
Cardiovascular disease
Compared with other regions, North America had the highest
mean BMI and the highest rates of hypertension and CVD in
both age groups (Table 2). Adjusted linear regression analysis de-
monstrated that mean preSBP was significantly higher among
pediatric and young adult patients in North America compared
with all other regions (all P < 0.02) (results not shown). PreSBP
and preDBP were positively correlated with age in both groups.
Males had significantly higher average preSBP readings, by
1.6 mmHg in the pediatric group and 6.0 mmHg in the young
adult group (P < 0.001 for both). No significant differences in
preSBP and preDBP were observed in pediatric patients by ESRD









































































































































































































































































































































































































































































































































































































































































































































































reference group, preSBP was significantly higher in young adults
with diabetes (by 10.5 mmHg, P < 0.001) or glomerular conditions
(by 2.7 mmHg, P = 0.013) as ESRD cause. When adjusting for race,
preSBP was still higher in North America, although white pa-
tients had lower preSBP by 6.2 mmHg compared with non-black
and non-Asian patients (Asian and black patients’ preSBP
was not significantly different from non-black and non-Asian
patients).
Mortality and hospitalizations
Death was uncommon in the pediatric sample (<1%) across
all regions. In the young adult group and using Europe as
the reference group, North America (OR 2.69; CI 1.29, 5.63) and
South America (OR 4.21; CI 2.32, 7.63) reported the highest OR of
death and Asia appeared to have a similar death rate compared
with Europe (Table 2). In both age groups, the number of hospita-
lizations occurred most frequently in North America (Table 2).
Access
In both age groups, the Asian cohort had the lowest rates of HD
catheters at the first HD treatment (45% in children and 42% in
young adults). South America and North America reported the
highest rates of catheter use among young adults (76 and 75%, re-
spectively) at dialysis initiation. In both age groups, catheter de-
pendence at 1 year was high in North America (77.3% in children
and 62.9% in young adults; Table 2). Access data at the specified
follow up time points were not available for South America. Ka-
plan–Meier curves demonstrated that these differences in cath-
eter use and dependence are statistically significant at 183 and
365 days of treatments (see Figure 2).
Treatment times and adequacy
The Asian pediatric and young adult patients had the longest
treatment times at 237 and 246 min, respectively, compared
with the North American cohorts with the lowest mean treat-
ment times reported, at 196 and 215 min, respectively (P < 0.001;
Table 3). The mean URR ranged from 69.8% in North America to
76.2% inAsia and eKt/V ranged from1.4 to 1.5 (Table 3). Using Eur-
ope as a reference group, males had significantly lower eKt/V in
both age groups. Among young adults, eKt/V was significantly
higher in the Asian and North American regions (P < 0.03 for









































































































































































































































































































































































































































































































































































































































































































































both) when adjusted for age, gender and cause of ESRD (data not
shown). We had no information on residual renal function.
Weight and inter-dialytic weight gain
The largest proportion of overweight and obese pediatric patients
was observed in North America (39 and 22%, respectively),
whereas the smallest was observed in Asia (8 and 6%,
respectively). In an adjusted linear regression using Europe as
the reference group, North American patients had significantly
greater BMI among young adults (by 5.5 kg/m2, P < 0.001).The
Asian young adult group had lower BMIs (by 1.4 kg/m2, P = 0.002).
Refer to Figure 3 for the relationship between BMI and hyperten-
sion by age and sex.
Serum albumin was higher in Asian pediatric and young
adult patients. In both age groups, the mean nPCR ranged from
0.8 g/kg/day in North American patients to 1.1 g/kg/day in
patients from Asia. Serum creatinine levels were also highest in
patients from Asia in both age groups (Table 3).
The mean IDWG ranged from 3.0% body weight to 4.3% in
both pediatric and young adult patients (Table 3). In an adjusted
linear regression model, compared with Europe, the mean IDWG
was significantly lower for North America in the pediatric group
(P = 0.04). In the pediatric group, patientswith diabetes had great-
er mean IDWG than those with other causes of ESRD.
Markers of inflammation
Ferritin levels were highest amongNorth American pediatric and
young adult patients compared with other regions. NLRs ranged
from 2.3 (pediatric Asia group) to 6.7 (pediatric North America
group). Highest NLR was observed in North America, while the
lowest were seen in the Asian region in both young adults and
pediatric patients (Table 3). CRP levels were not reported for
North American patients of either age group.
Discussion
The PICCOLO MONDO is a unique longitudinal cohort that offers
a view of baseline and 1-year outcomes in 0- to 30-year-old pa-
tients receiving HD through a single dialysis provider in several
regions of the world. This unique opportunity was possible due
to the good will of all volunteer MONDO Consortium participants
[7, 8]. The sample size allowed us to characterize pediatric and
young adult HD patients with conditions such as diabetes, ex-
panding the CKiD Study diagnosis criteria [9].
For those with known cause of ESRD, CAKUT had the highest
prevalence in Europe in both age groups. Glomerular conditions
had the greatest number of cases reported in both age groups in
North America and in Asia. We observed that patients in North
America and Asia had similarly elevated rates of diabetes as a
cause of ESRD in both age groups. The significance of this finding
is unclear, but a possible explanationmay be related to the preva-
lence of autoimmune conditions in these populations. In our
Fig. 2. (a) Kaplan–Meier analysis of catheter prevalence over 183 days (log-rank
test; P = 0.03). (b) Kaplan–Meier analysis of catheter prevalence over 365 days
(log-rank test; P < 0.001).

















≤18 Asia 4.1 (0.4) 8.8 (3) 1.1 (0.1) 4.3 (2.2) 237 (16.8)* 76.2 (5.8) 1.5 (0.3) 7.9 (10.6) 443.3 (250.6) 2.3 (1.4)
Europe 3.9 (0.6) 7.8 (2.4) 1 (0.1) 3.7 (1.6) 229 (24.7) 73 (7.9) 1.4 (0.3) 12.1 (18) 317.9 (288) 3.6 (5)
North America 3.8 (0.6) 8.6 (3.3) 0.8 (0.2) 3.1 (1.5) 196 (15.9) 69.8 (10.9) 1.5 (0.4) 516.7 (1281.9) 6.7 (11)
South America 3.7 (0.6) 7.4 (3.4) 1 (0.1) 3.8 (1.9) 228 (25.9) 74 (7.6) 1.4 (0.4) 9.4 (18.8) 383.2 (315) 3.2 (3.7)
>18 Asia 4 (0.5) 9.5 (3) 1.1 (0.1) 3.9 (2) 246 (24.4)* 73.1 (7.2) 1.4 (0.3) 10.3 (18) 456.9 (274.4) 3 (2.3)
Europe 3.9 (0.5) 9.3 (2.6) 1 (0.1) 3 (1.4) 235 (22.7) 73.1 (7.5) 1.4 (0.3) 9.2 (15.9) 340.3 (243.5) 3.2 (3.3)
North America 3.9 (0.5) 9.5 (3.4) 0.8 (0.2) 3.3 (1.4) 215 (25.1) 71.3 (7.5) 1.4 (0.3) 503.9 (523.2) 4.1 (3.9)
South America 3.9 (0.5) 9 (3.5) 1 (0.1) 3.8 (1.8) 239 (9.8) 72.8 (8.1) 1.4 (0.3) 7.2 (13.2) 395.1 (313.1) 3.1 (2.6)
Data are presented as mean (±SD).
IDWG, inter-dialytic weight gain; URR, urea reduction rate; CRP, C-reactive protein; NLR, neutrophil-to-lymphocyte ratio.
*P < 0.001.


















cohort, we did not have granular information regarding the type
of diabetes as the primary cause of ESRD. In a population-based
study in Singapore, higher rice and noodle consumption was as-
sociatedwith greatermarkers of insulin resistance and hypergly-
cemia [12]. Furthermore, in an international registry of the USA
and Europe, with nearly 33 000 pediatric patientswith Type 1 DM,
it was reported that 12% (n = 3977) of children in both registries
combined were considered obese, 24% (n = 7825) or overweight,
64% (n = 20 942), based on theWorld Health Organization classifi-
cation of BMI [13].
The PICCOLO MONDO cohort highlights the greater preva-
lence of cardiovascular risk factors (overweight, obesity and
hypertension) in both age groups of North American patients
compared with other regions, reflective of similar findings in
the general worldwide population [14]. Figure 3 depicts the direct
relationship between BMI and preSBP. As in older adults with
ESRD, cardiovascular comorbidities are highly prevalent in both
pediatric and young adult patients in all regions, although to
varying degrees. In the USA, young adult ESRD patients have a
100-fold higher cardiovascular mortality rate than the general
population [15]. Our study would support the same findings,
but the magnitude may differ in other countries.
In an adult-based international study of HD patients, the USA
has the highest rates of catheter use, followed by Europe and
Japan [16]. Our study also showed high rates of HD catheter use
(at baseline and 1-year follow-up) in North America, possibly as-
sociated with higher markers of inflammation. The lower IDWG,
expressed as a percentage, in the North American and the Euro-
pean regions may be related to the higher BMI in these regions.
The lower prevalence of hypertension in European patients
may reflect the greater number of patients with GU anomalies
as the cause of ESRD, who typically have a high urinary output
and less hypertension.
While payer incentives and best practices vary by region,
campaigns such as the ‘fistula first’ started in the USA during
our study period. In North America, the catheter dependence in
the pediatric cohort was greater than in the young adults of
this region. This latter grouphad similar catheter use to theMedi-
care population in 2006 [17]. North America also had the highest
odds of hospitalizationwhen comparedwith the other regions in
both age groups, whereas these outcomes aremulti-factorial, the
significantly greater catheter use in North America may in fact
contribute to this outcome.
Although dialysis adequacy asmeasured by eKt/Vwas similar
in all regions, North America had the shortest overall treatment
times, whereas Asia had the longest overall treatment times.
North America also had lower nPCR when compared with other
countries, as well as higher inflammatory markers. Our findings
related to the nPCR and CVD among Asians warrant discussion.
In the general population, protein intake varies by region, but
even within countries, cultural differences are noted in soy-
based protein intake. In a community-based study in Canada
for example, Asians consume more soy products compared
with others [18]. Diet changes have been observed in the cohort
followed by the Mediators of Atherosclerosis in South Asians
Living in America Study, where the intake of nutrients such as
protein and fiber were inversely associated with the length of
residence in the USA (P trend <0.05) [19]. Greater soy food con-
sumption has been associated with less lipid abnormalities, hy-
peruricemia and cardiometabolic disturbances, particularly in
women from a community-based study in China [20]. CRP level,
a marker of inflammation, has been associated with dietary pat-
terns in a population-based study of Koreans, where men with
hypertension in the ‘vegetable’ pattern group had lower CRP
levels [21]. In an Asian population of patientswith CKD, 24-h urin-
ary protein excretion exceeded the recommended guidelines [22].
The PICCOLO MONDO cohort is quite different from national
samples represented in databases such as the USRDS [1]. The ad-
vantage of this study is that it provides a unique opportunity to
explore the segment of the child and young adult ESRD popula-
tion managed in adult-oriented dialysis units. Most children
and younger adolescents are treated by pediatric sub-specialists
in developed countries, whereas adolescents >16 years of age are
commonly treated by adult-focused specialists. The focus of the
nephrologist as adult- or child-orientedmay influence how pedi-
atric dialysis patients are viewed and treatedwithin dialysis facil-
ities [6]. The results of our analysis of children, adolescents and
young adults in this cohort are consistent with the findings of
treatment characteristics and behaviors described in cohorts of
adult ESRD patients. For example, the Dialysis Outcomes and
Practice Patterns (DOPPS) study showed that patients in the
USAhave consistently shorter treatment times than those in Eur-
ope or Japan [23]. Practices in South America were not analyzed
by this DOPPS study.
Compared with the pediatric USRDS populations [1], this
sample includes young adults, who aremore likely to have glom-
erular disease. An important analysis that we were unable to
address would be the comparison of outcomes by dialysis envir-
onment (adult versus pediatric oriented) with age and region
matching. Such a study in the futuremay highlight opportunities
to improve practice and outcomes in both types of dialysis
practices.
Among our limitations, PICCOLO MONDO consists of dialysis
providers interested in participating in this research initiative
Fig. 3. (a) Mean BMI (in kg/m2) and preSBP (mmHg) in female patients. (b) Mean
BMI (in kg/m2) and preSBP (mmHg) in male patients.


















andwho are not representative of all patients in the countries in-
cluded. Pediatric and young adults in the North America region
represent 5 and 12%, respectively, of the 2011 USRDS population
[1]. To overcome different disease classification systems, we
developed an equivalency algorithm. North America had the
highest number of patients with a known cause of ESRD in both
age groups. South America had the largest number of pediatric
patients, but we were unable to determine their ESRD cause
and 1-year dialysis access due to lack of documentation [7]. Over-
all, data were limited from South America, which made some
comparisons and analyses difficult; however, important infor-
mationwas gleaned about this regionwith regard to demograph-
ics, comorbidities and clinical and laboratory characteristics.
We had no information on residual renal function and the type
of diabetes as the primary cause of ESRD. Also, in the European
and Asia Pacific datasets, race information is not recorded,
so we made assumptions on the race of the patients; in South
America, a number of patients had missing race information.
We defined overweight and obesity based on one of the inter-
national definitions for children by Cole et al. [11], although we
acknowledge that other methods exist for obesity classification
around the world. Further, adjusted analysis may be necessary
to account for the differences in hospital admission rates and in-
flammatorymarkers. Finally, because this is a de-identified regis-
try, we cannot confidently say which patients came from
pediatric only units versus unitswith amix of adult and pediatric
patients. On the basis of a surveyof the participating partners, we
found thatmost clinics are not pediatric-specific. Because of this,
pediatric data discussed in thismanuscript may not be represen-
tative of the pediatric ESRD population.
Conclusions
The PICCOLOMONDOcohort describes and compares longitudin-
al data from pediatric and young adult HD patients within a
single international dialysis provider system, and itwas only pos-
sible by the good will and collaboration from all participating
sites. Catheters for HD access are commonly used at initiation
in both age groups and persist at 1 year across all regions. How-
ever, North American facilities rely on catheters more than
other regions. Similarly, obesity and hypertension aremost com-
mon in the Americas and represent a potential intervention tar-
get to reduce the long-term risk of cardiovascular comorbidities.
Despite differences in treatment times, adequacy was similar in
all regions. While these differences were observed in pediatric
and adolescent patients, they may not be specific to these
patients and point out a general ESRD patient care issue in
those respective regions. This study highlights areas where
further investigation is needed.
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